Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence

• Main Authors: Antonio Arrieta (Author), Alvaro E. Galvis (Author), Stephanie Osborne (Author), Tricia Morphew (Author), Karen Imfeld (Author), Claudia Enriquez (Author), Janet Hoang (Author), Marcia Swearingen (Author), Delma J. Nieves (Author), Negar Ashouri (Author), Jasjit Singh (Author), Diane Nugent (Author)
• Format: Book
• Published: MDPI AG, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Data on COVID-19 convalescent plasma (CCP) safety and efficacy in children and young adults are limited. This single-center prospective, open-label trial evaluates CCP safety, neutralizing antibody kinetics, and outcomes in children and young adults with moderate/severe COVID-19 (April 2020-March 20...